secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAGENICS INC (OGEN)
CIK:        0001174940
Form:       8-K
Filed at:   2024-03-01T23:59:59+00:00
Accession:  0001493152-24-008489
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oragenics closes $2.1M public offering of 1.4M shares; funds ONP-002 development
--------------------------------------------------------------------------------

- Issued 1,400,000 shares at $1.50/share for gross proceeds of $2.1M.
- Underwriters granted a 45-day option for up to 210,000 additional shares.
- Net proceeds to fund continued development of ONP-002 for concussion treatment.
- Representative's warrants issued for up to 5% of Shares at $1.875/share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1174940/000149315224008489/0001493152-24-008489-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1174940/000149315224008489/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-008489

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer